Origin created the name PREZISTA for Tibotec, a division of Johnson & Johnson. Prezista is a new HIV protease inhibitor for adults who have not responded to treatment from other antiretroviral drugs.
Derived from ‘resistance’; somewhat dynamic feel suggests efficacy and power, differentiated within category
